Page 6 - Lancet Report

119,000 Indian children lost caregivers due to Covid in 14 months: Report

More than 1.5 million children in 21 countries, including 119,000 from India, lost their primary and secondary caregivers to Covid-19 during the first 14 months of the pandemic, according to Lancet

Alcohol linked to over 62,000 cancer cases in India last year: Lancet study

Alcohol consumption was associated with 62,100 or five per cent of newly diagnosed cancer cases last year in India, according to a study published in The Lancet Oncology journal

Pfizer jab produces less antibodies against Delta variant: Lancet

People fully vaccinated with two doses of the Pfizer-BioNTech vaccine are likely to have more than five times lower levels of neutralising antibodies against the Delta variant

India could see 1 million Covid-19 deaths by August 1, says Lancet

The editorial in the medical journal has quoted Institute for Health Metrics and Evaluation data

Study sheds light on ten reasons why the coronavirus is airborne: Lancet

The evidence supporting airborne transmission is overwhelming, and evidence supporting large droplet transmission is almost non-existent, says a researcher

Bharat Biotech's Covaxin safe, immunises for at least 3 months: Lancet

Probability of side effects from vaccine 10-12%, 6x lower than other shots

Bharat Biotech's Covaxin has tolerable safety, says Lancet study

Sharing the interim findings, the paper said that the vaccine was well tolerated in all dose groups with no vaccine-related adverse events

Improving India's air may prevent 7% of pregnancy losses: Lancet

In a first, a Lancet study has indicated that meeting India's air quality targets across south Asia may prevent 7 per cent of pregnancy losses

Ban on public events can curb Covid transmission rate by 24%: Lancet study

Customers can book the model at their nearest Ducati dealerships, and the deliveries will begin in the first week of November, it added

India gained more than a decade of life expectancy since 1990: Lancet

The study, published in the Lancet journal, noted that life expectancy in India has risen from 59.6 years in 1990 to 70.8 years in 2019, ranging from 77.3 years in Kerala to 66.9 years in UP

Russia's Covid-19 vaccine shows potential in peer review, Lancet reports

Sputnik V induced an antibody response in all participants in early trials and found no serious adverse effects.

Oxford-Astra Covid-19 vaccine shows dual immune action, says researcher

Study shows the vaccine is safe, but it is still too soon to know if it can stop people from being infected

Covid-19 vaccine: Oxford candidate safe, shows immune response in trial

The preliminary results of the phase 1-2 trial, published in The Lancet journal, involved 1,107 healthy adults, and found that the vaccine induced an immune response both via antibodies and T-cells

Contact tracing won't curb Covid-19 spread if testing is too slow: Lancet

To be successful, contact tracing measures must keep the rate of transmission of the virus, known as the Reproduction or R number, below one

MP, Bihar, Telangana districts most vulnerable to Covid-19: Lancet study

Nine states marked out for higher risks, based on five parameters selected by researchers

China has its work cut out: India to be world's largest employer in 2100

Population to decline from a peak in 2048 to a 32% lower level by 2100: The Lancet

Lancet study casts doubt over herd immunity for tackling Covid-19

For herd immunity to work, at least 70 per cent of a population needs to be immune to protect the uninfected people, experts say

Amidst controversy, Indian companies continue to manufacture HCQ

Once touted as a 'wonder drug', HCQ has been battling global controversies around its safety and efficacy as a prophylactic against the new coronavirus SARS-CoV-2.

Is India right in recommending HCQ despite the uncertainties around it?

HCQ was dropped from the solidarity trial that WHO was conducting as a part of a global effort in May.

Covid-19 crisis: WHO says HCQ trials can resume, safety test done

The World Health Organization said Wednesday that it will resume recruiting patients for the hydroxychloroquine arm of a global trial called Solidarity.